← FDA Drug Approvals (Drugs@FDA)

DIFLUNISAL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 1992-07-31

Drug application

FDA Application #

ANDA073673

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIFLUNISAL

Generic name

DIFLUNISAL

Active ingredients

DIFLUNISAL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

1992-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown